Northwire Canada EditionMonday, August 24, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% EML 0.225 −4.3% GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% EML 0.225 −4.3%
Other Routine +

TerrAscend Files Preliminary Proxy Statement for Special Meeting of Shareholders in Preparation for Uplisting to US Exchange

TerrAscend Files Proxy for Reverse Split; Uplisting Remains a Mechanical Step, Not a Fundamental Catalyst

By The Northwire Desk — AI Analysis Jun 29, 2026 · 11:00 TSND · 0.94 TERRASCEND CORP. J
Executive Summary
  • TerrAscend filed a preliminary proxy statement to propose a share consolidation at a Special Meeting of Shareholders on August 24, 2026.
  • The consolidation ratio will be determined by the Board within a range of 1:5 to 1:20 pre- to post-consolidation shares.
  • The strategic rationale is to meet minimum share price requirements for a potential uplisting to a major U.S. stock exchange.
  • Management cites the U.S. Department of Justice's April 2026 rescheduling of medical cannabis to Schedule III as a meaningful regulatory catalyst supporting the uplisting timeline.
  • The Board recommends shareholders vote in favor of the consolidation.
Material Impact
  • The share consolidation is a mechanical prerequisite for a U.S. exchange listing, a goal management has signaled for years. It is Routine - Positive. The stock's -6% decline into the print indicates the market views this as a low-information event. The proxy filing itself does not alter near-term cash flows, earnings power, or balance sheet risk. The real catalysts remain the Schedule III tax relief, successful Michigan exit completion, and sustained Northeast execution.
TSND · Price
Company Overview
  • TerrAscend Corp. is a vertically integrated cannabis operator and retailer with a footprint across New Jersey, Maryland, Pennsylvania, Ohio, and Canada. The company focuses on premium retail brands (Apothecarium) and private-label products, leveraging celebrity partnerships (Tyson 2.0) and strategic acquisitions to expand its Northeast U.S. presence.
Read the original news release →

More from TERRASCEND CORP. J

Jun 30, 2026 · 08:30

Small accretive NJ acquisition and reverse-split proxy fail to offset lingering debt and Michigan receivership overhang.

M&A / Property Jun 25, 2026 · 16:00

Debt maturity extension and M&A war chest, but conversion discount and Michigan receivership cloud the balance sheet.

Financings Jun 05, 2026 · 14:26

TerrAscend Schedules Special Meeting of Shareholders in Preparation for U.S. Stock Exchange Uplisting

Other May 07, 2026 · 07:10

TerrAscend Confirms Cash Flow Streak Amidst Regulatory Tailwinds

Earnings Apr 27, 2026 · 08:35

TerrAscend Stabilizes Cash Flow Amidst Cannabis Sector Volatility

Earnings Mar 31, 2026 · 20:15

Terrascend releases Tyson 2.0 in Pennsylvania, Maryland

Other